WELL Health Q2 revenue beats expectations on HEALWELL AI inclusion, reaffirms annual rev guidance

Overview

• WELL Health Q2 2025 revenue grows 57% yr/yr, beating analyst expectations, per LSEG data

• Adjusted EBITDA rises 231% yr/yr, reaching C$49.7 mln, driven by organic growth, acquisitions

Outlook

• WELL reaffirms 2025 revenue guidance between C$1.40 bln to C$1.45 bln

• Company expects 2025 Adjusted EBITDA between C$190 mln to C$210 mln

• WELL aims for upper half of guidance ranges with planned acquisitions

Result Drivers

• ORGANIC GROWTH - Co attributes 57% revenue increase to organic growth and acquisitions

• HEALWELL AI CONTRIBUTION - Inclusion of HEALWELL AI added C$40.5 mln to Q2 revenue

• CANADIAN PATIENT SERVICES - Revenue from Canadian Patient Services grew 49%, driven by organic growth and acquisitions

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

• Wall Street's median 12-month price target for WELL Health Technologies Corp is C$7.68, about 34.6% above its August 13 closing price of C$5.02

• The stock recently traded at 88 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nBw2hfTxQa